Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human BCG Challenge Model for TB Drugs and Vaccines
NCT05592223Phase 1Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Dec 2022
- Primary completion
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bcg vaccine in Tuberculosis (TB), sponsored by Fred Hutchinson Cancer Center. Started Dec 2022; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05592223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05592223.